Midgard
Hemogenix

Hemogenix

Colorado Springs, CO, United States hemogenix.com From their website, Nov 2026

  • GLP

Work here? Claim this listing

About

HemoGenix provides contract research services focused on in vitro toxicology, cell-based assays, and potency testing for biopharmaceutical, cellular therapy, and regenerative medicine clients. It works with primary cells, human tissue, animal tissues, and tumor cells to assess toxicity, mechanism of action, and product quality. The company is based in Colorado Springs, Colorado.

Hemogenix is a CRO in Colorado Springs, CO, founded in 2000. It lists 20 services, including High-throughput screening, Stem cell toxicity and Bone marrow toxicity and stem cell hematotoxicity. It names GLP on its listing.

Services

  • High-throughput screening

    Performs high-throughput screening using primary cell systems, cell lines, and tumor cells for comparative toxicity screening and compound ranking.

  • Stem cell toxicity

    Evaluates toxicity in stem cell systems, including stem cell hematotoxicity and related biology.

  • Bone marrow toxicity and stem cell hematotoxicity

    Assesses toxicity effects on bone marrow and hematopoietic stem cell systems.

  • Immunotoxicity

    Tests compounds for effects on the immune system using in vitro assay platforms.

  • Mesenchymal cell toxicity

    Measures toxic effects in mesenchymal cell systems.

  • Hepatotoxicity

    Assesses liver toxicity in in vitro models.

  • Cardiotoxicity

    Assesses heart-related toxicity using cell-based assays.

  • Neurotoxicity

    Assesses nervous system toxicity in in vitro models.

12 more services
  • Renal toxicity
  • Skin toxicity
  • Intestinal toxicity
  • Genotoxicity
  • Nanoparticle toxicity panel testing
  • Mechanism of Action (MOA)
  • Drug-drug interaction and combination therapy
  • Biologics, small molecule and drug functionality and potency testing
  • Stem cell potency and quality testing for cellular therapeutics
  • Customized basic research on several biological systems
  • Cell-based assay services
  • IND-enabling assays
Turnaround
  • Most in vitro studies are completed within 7-14 days.
  • Phase I Report is usually provided within 5 - 7 business days after study completion.

How to order from Hemogenix

Turnaround they state: Most in vitro studies are completed within 7-14 days; Phase I Report is usually provided within 5 - 7 business days after study completion. They take requests through the contact form on their website. You can contact them directly from this page, or request a quote through Midgard.

Capabilities

Assays and studies
  • Cell-based assays
  • HTS
  • In vivo
  • Cell therapy
  • Rodent models
  • Toxicology
16 more
  • Small molecules
  • Hematotoxicity
  • Immunotoxicity
  • Mesenchymal stem cell toxicity
  • Hepatotoxicity
  • Cardiotoxicity
  • Neurotoxicity
  • Renal toxicity
  • Skin toxicity
  • Intestinal toxicity
  • Genotoxicity
  • Drug interaction
  • Combination therapy
  • Mechanism of action
  • Potency assay
  • Quality assay
Therapeutic areas
  • Cell therapy
  • Regenerative medicine

Modalities and species

Modalities
  • Small molecule
  • Cell therapy
Species and models
  • Primate
  • Minipig
  • Dog
  • Rat
  • Mouse
  • Human tissue
9 more
  • Primary cells
  • Cryopreserved primary cells
  • Tumor cells
  • Bone marrow
  • Umbilical cord blood
  • Peripheral blood
  • CD34+ cells
  • CD133+ cells
  • Mesenchymal stem/stromal cells

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GLPSelf-reported

    Scope: Customized, full-service studies

Details

Type
CRO
Founded
2000
Based in
Colorado Springs, CO, United States
Serves
World-wide

Similar labs